Advanced Biomed Inc. (ADVB): Total Assets
$13.75M
As of 2026-06-30
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2026-06-30 | $13.75M | -39.9% | 2026-10-13, Balance as of period end |
| 2025-06-30 | $22.86M | +412.6% | 2026-10-13, Balance as of period end |
| 2024-06-30 | $4.46M | n/a | 2025-10-08, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | 2026-06-30 | $13.75M | -39.9% |
| YD Bio Ltd (YDES) | 2025-12-31 | $13.78M | +100.7% |
| Aclarion, Inc. (ACON) | 2025-12-31 | $13.67M | +543.9% |
| BioNexus Gene Lab Corp (BGLC) | 2025-12-31 | $9.25M | -11.3% |
| CapForce Inc. (CFOR) | 2025-12-31 | $38.06M | +285.8% |
| First Choice Healthcare Solutions, Inc. (FCHS) | 2025-12-31 | $4.05M | -10.3% |
| American Shared Hospital Services (AMS) | 2025-12-31 | $55.48M | -7.8% |
| Exagen Inc. (XGN) | 2025-12-31 | $58.02M | +29.8% |
| Biodesix Inc (BDSX) | 2025-12-31 | $87.48M | -10.0% |
Compare ADVB, YDES, ACON, BGLC side by side · Screen every company in Services-Medical Laboratories ↗